Literature DB >> 12638020

Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease.

Knut Brockmann1, Peter Dechent, Moritz Meins, Mechthild Haupt, Jürgen Sperner, Ulrich Stephani, Jens Frahm, Folker Hanefeld.   

Abstract

Alexander disease (AD) is a rare genetic disorder of the central nervous system due to a dysfunction of astrocytes. The most common infantile form presents as a progressive leukodystrophy with macrocephalus. Recently, heterozygous de novo mutations in the gene encoding glial fibrillary acidic protein (GFAP) have been demonstrated to be associated with AD. We used localized proton magnetic resonance spectroscopy (MRS) to assess metabolic abnormalities in grey and white matter, basal ganglia, and cerebellum of 4 patients with infantile AD and GFAP mutations. Strongly elevated concentrations of myo-inositol in conjunction with normal or increased choline-containing compounds in all regions investigated point to astrocytosis and demyelination. Neuroaxonal degeneration, as reflected by a reduction of N-acetylaspartate, was most pronounced in cerebral and cerebellar white matter. The accumulation of lactate in affected white matter is in line with infiltrating macrophages. Metabolic alterations demonstrated by in vivo proton MRS are in excellent agreement with known neuropathological features of AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12638020     DOI: 10.1007/s00415-003-0995-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

Review 1.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 2.  Advanced imaging in paediatric neuroradiology.

Authors:  Mehmet Kocak
Journal:  Pediatr Radiol       Date:  2009-06

Review 3.  Clinical 1H MRS in childhood neurometabolic diseases - part 2: MRS signatures.

Authors:  Matthew T Whitehead; Lillian M Lai; Stefan Blüml
Journal:  Neuroradiology       Date:  2022-02-28       Impact factor: 2.804

Review 4.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

5.  Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior.

Authors:  Ilse Gantois; Ke Fang; Luning Jiang; Daniela Babovic; Andrew J Lawrence; Vincenzo Ferreri; Yaroslav Teper; Bianca Jupp; Jenna Ziebell; Cristina M Morganti-Kossmann; Terence J O'Brien; Rachel Nally; Günter Schütz; John Waddington; Gary F Egan; John Drago
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

6.  ¹H-MR spectroscopy of adult-onset autosomal dominant leukodystrophy with autonomic symptoms.

Authors:  J Finnsson; A Melberg; R Raininko
Journal:  Neuroradiology       Date:  2013-05-01       Impact factor: 2.804

7.  Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction.

Authors:  Paul L Wood; Tara Smith; Lindsay Pelzer; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-06-17       Impact factor: 3.876

8.  GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Authors:  M Prust; J Wang; H Morizono; A Messing; M Brenner; E Gordon; T Hartka; A Sokohl; R Schiffmann; H Gordish-Dressman; R Albin; H Amartino; K Brockman; A Dinopoulos; M T Dotti; D Fain; R Fernandez; J Ferreira; J Fleming; D Gill; M Griebel; H Heilstedt; P Kaplan; D Lewis; M Nakagawa; R Pedersen; A Reddy; Y Sawaishi; M Schneider; E Sherr; Y Takiyama; K Wakabayashi; J R Gorospe; A Vanderver
Journal:  Neurology       Date:  2011-09-14       Impact factor: 11.800

9.  Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation.

Authors:  J Chiappelli; L E Hong; S A Wijtenburg; X Du; F Gaston; P Kochunov; L M Rowland
Journal:  Transl Psychiatry       Date:  2015-04-14       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.